Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche's Endocannabinoid System Projects.
Aebi J, Atz K, Ametamey SM, Benz J, Blaising J, Butini S, Campiani G, Carreira EM, Collin L, De Lago E, Gazzi T, Gertsch J, Gobbi L, Guba W, Fernández-Ruiz J, Fingerle J, Haider A, He Y, Heitman LH, Honer M, Hunziker D, Kuhn B, Maccarrone M, Märki HP, Martin RE, Mohr P, Mu L, Nazaré M, Nippa DF, Oddi S, O'Hara F, Pacher P, Romero J, Röver S, Rufer AC, Schibli R, Schneider G, Stepan AF, Sykes DA, Ullmer C, Van der Stelt M, Veprintsev DB, Wittwer MB, Grether U. Aebi J, et al. Among authors: mohr p. Chimia (Aarau). 2024 Aug 21;78(7-8):499-512. doi: 10.2533/chimia.2024.499. Chimia (Aarau). 2024. PMID: 39221845 Free article.
Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System.
Edelmann MR, Bredack C, Belli S, Mohr P, Imhoff MP, Reggiani F, Kusznir EA, Rufer AC, Holt DP, Valentine H, Wong DF, Dannals RF, Honer M, Gobbi LC. Edelmann MR, et al. Among authors: mohr p. Bioconjug Chem. 2023 Oct 18;34(10):1882-1893. doi: 10.1021/acs.bioconjchem.3c00385. Epub 2023 Sep 14. Bioconjug Chem. 2023. PMID: 37710950
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncology.
Kandolf L, Ascierto PA, Bastholt L, Gavrilova I, Haanen J, Hauschild A, Herceg D, Hoeller C, Jalovcic Suljevic A, Kessels JI, Krajsova I, Kukushkina M, Lallas A, Lorigan P, Mangana J, Marquez-Rodas I, Mazilu L, Mohr P, Bylaite-Bucinskiene M, Ocvirk J, Olah J, Putnik K, Rutkowski P, Saiag P, Samolyenko I, Schwarze JK, Stojkovski I, Cicmil Sarić N, Vieira R, Weichenthal M, Garbe C. Kandolf L, et al. Among authors: mohr p. Eur J Cancer. 2024 Nov 16;216:115124. doi: 10.1016/j.ejca.2024.115124. Online ahead of print. Eur J Cancer. 2024. PMID: 39721295
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg.
Kött J, Zell T, Zimmermann N, Rünger A, Smit DJ, Abeck F, Geidel G, Hansen-Abeck I, Heidrich I, Weichenthal M, Ugurel S, Leiter U, Berking C, Gutzmer R, Schadendorf D, Zimmer L, Livingstone E, Wasielewski IV, Mohr P, Meier F, Haferkamp S, Drexler K, Herbst R, Kellner I, Utikal J, Wohlfeil SA, Pföhler C, Adam L, Terheyden P, Ulrich J, Meiss F, Möbes M, Welzel J, Schilling B, Ziller F, Kaatz M, Kreuter A, Sindrilaru A, Dippel E, Sachse M, Weishaupt C, Hüning S, Heinzerling L, Loquai C, Schley G, Gambichler T, Löffler H, Grabbe S, Schultz E, Devereux N, Hassel JC, Simon JC, Raap U, Assaf C, Klemke CD, Sunderkötter C, Hofmann SC, Wenk S, Tronnier M, Thies S, Heppt MV, Eggermont A, Schulze HJ, Zouboulis CC, Tüting T, Bauer AT, Schneider SW, Gebhardt C. Kött J, et al. Among authors: mohr p. Eur J Cancer. 2025 Jan;214:115159. doi: 10.1016/j.ejca.2024.115159. Epub 2024 Nov 30. Eur J Cancer. 2025. PMID: 39642845 Free article.
Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma.
Gutzmer R, Leiter U, Mohr P, Kähler KC, Ascierto PA, Scalvenzi M, Peris K, Pérez-Pastor GM, Fernández-de-Misa R, Botella-Estrada R, Hunger RE, Martelli S, Güneli N, Arntz R, Hauschild A. Gutzmer R, et al. Among authors: mohr p. BMC Cancer. 2024 Nov 14;24(1):1401. doi: 10.1186/s12885-024-13101-z. BMC Cancer. 2024. PMID: 39538176 Free PMC article.
Long Axial Field of View PET/CT: Technical Aspects in Cardiovascular Diseases.
Martinez-Lucio TS, Mendoza-Ibañez OI, Liu W, Mostafapour S, Li Z, Providência L, Salvi de Souza G, Mohr P, Dobrolinska MM, van Leer B, Tingen HSA, van Sluis J, Tsoumpas C, Glaudemans AWJM, Koopmans KP, Lammertsma AA, Slart RHJA. Martinez-Lucio TS, et al. Among authors: mohr p. Semin Nucl Med. 2025 Jan;55(1):52-66. doi: 10.1053/j.semnuclmed.2024.10.009. Epub 2024 Nov 13. Semin Nucl Med. 2025. PMID: 39537432 Free article. Review.
Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.
Weichenthal M, Mangana J, Gavrilova I, Lugowska I, Shalamanova GK, Kandolf L, Chiarion-Sileni V, Mohr P, Karanikolova TS, Teterycz P, Espinosa E, Schnecko P, Cheng P, Bender M, Jiang S, Burke T, Ascierto PA, Gogas H, Rodas IM, Rutkowski P, Schadendorf D, Dummer R, For The EUMelaReg Consortium. Weichenthal M, et al. Among authors: mohr p. Cancers (Basel). 2024 Oct 22;16(21):3558. doi: 10.3390/cancers16213558. Cancers (Basel). 2024. PMID: 39517999 Free PMC article.
Advances and challenges in immunoPET methodology.
Mohr P, van Sluis J, Lub-de Hooge MN, Lammertsma AA, Brouwers AH, Tsoumpas C. Mohr P, et al. Front Nucl Med. 2024 Feb 19;4:1360710. doi: 10.3389/fnume.2024.1360710. eCollection 2024. Front Nucl Med. 2024. PMID: 39355220 Free PMC article. Review.
591 results